Delivery Order SPE2DB22D1106-SPE2DB24FESC2
- Not listed
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The award, valued at $2,375.10, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,008.40 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,389.84 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,944.69 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 7, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,589.69 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract does not have a set-aside...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,371.22 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 11, 2023, with a completion date of May 12, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S" to the Defense Logistics Agency (DLA), a defense agency. The $1,192.24 firm fixed-price delivery order contract has a completion date of May 7, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
- This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,470.89 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,478.97, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 18, 2024. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The contract, valued at $1,059.88, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is a delivery order contract with a firm fixed price, and the ultimate completion date is June 21, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FESC2Delivery Order
This federal contract award is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,019.04 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical supplies to the U.S. government, through its Corporate Office division. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical commodities to the Department of Defense worldwide. This delivery order is one of the individual orders placed against that larger IDC. The contract has no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 5/15/24 |